DEC 10, 2015 2:02 PM PST

Captured Images Show Immune Cells Chasing Cancer Cells

WRITTEN BY: Kara Marker
Superior technology brings us novel images of cancer cells and lymphocytes this week, and now scientists can learn more about how our body fights back against metastasizing tumors.

Using a sophisticated microscope, scientist Bettina Weigelin from Radboud University Medical Center in the Netherlands observed and logged cancer cells moving through paths in the body made by blood vessels, muscle tissues, and nerves. Immune cells followed as expected, pursuing the abnormal cells to kill them. The imaging technology, called a multiphoton laser scanning microscope (MPLSM), provides “high resolution fluorescence imaging, allowing visualization of cellular structures of epidermis” (Seminars in cutaneous medicine and surgery). Making these observations will help scientists visualize the effectiveness of immunotherapy in treating skin cancer, as Weigelin did with cytotoxic T cells.
An illustration of cytotoxic T cells attached to a cancer cell

Weigelin’s observations indicated that cancer cell metastasis is not random. As they travel through paths already existing in the body, they “choose the path of least resistance.”

“Never before has this migration behavior of tumor cells been recorded with such clarity,” stated a press release from Radboud.

Weigelin’s studies also lend insight into the battle between immune cells and cancer cells. Can immune cells defeat cancer cells before there are too many to control or they become resistant?

Weigelin looked at the cytotoxic T cell attack on cancer cells and saw that tissues with high concentrations of cytotoxic T cells were most successful in killing populations of cancer cells.

It makes sense then that a form of immunotherapy would be to inject an army of cytotoxic T cells into the body. Weigelin’s observations showed two important factors in immunotherapy attack: cytotoxic T cell numbers and their ability to burst tumor cells. Moreover, a large number of extremely effective cytotoxic T cells is the best defense against tumors.

However, cancer cells can still become resistant to cytotoxic T cell immunotherapy. A known alternative involves recruiting monoclonal antibodies, “signal substances that adhere to the cancer cells,” alerting the immune cells of their presence for quicker detection and deletion. Although it is also possible for cancer cells to become resistant to monoclonal antibody therapy, when both cytotoxic T cell and monoclonal antibody immunotherapies are applied, it is possible to overwhelm the tumor and avoid resistance.

Watch the following video to see cytotoxic T cells in action:

Source: Medical News Today
 
About the Author
Master's (MA/MS/Other)
I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 03, 2022
Clinical & Molecular DX
Co-Infections of COVID-19 and the Flu were Common Last Winter, Researchers Find
Co-Infections of COVID-19 and the Flu were Common Last Winter, Researchers Find
Infections of SARS-CoV-2, or COVID-19, do not always occur on their own. A COVID-19 infection can occur at the same time ...
NOV 17, 2022
Cancer
Anti-Aging Supplement Linked to Aggressive Breast Cancer
Anti-Aging Supplement Linked to Aggressive Breast Cancer
Vitamin B3, also known as niacin, is a generic name for a group of biochemical compounds, including nicotinamide ribosid ...
NOV 29, 2022
Microbiology
It's Strep Throat Season
It's Strep Throat Season
HardyCHROM™ Group A Strep Agar is our easy-to-read, chromogenic media recommended for the selective cultivation an ...
DEC 14, 2022
Clinical & Molecular DX
Scientists Identify Compound that Could Broadly Fight Coronavirus Infections
Scientists Identify Compound that Could Broadly Fight Coronavirus Infections
Researchers at the University of British Columbia have identified a compound that shows promise in targeting a wide rang ...
JAN 19, 2023
Drug Discovery & Development
Introducing TruCytes™: The Ready-to-Use Immunophenotyping Control for Cell Therapy, Flow Cytometry and Beyond
Introducing TruCytes™: The Ready-to-Use Immunophenotyping Control for Cell Therapy, Flow Cytometry and Beyond
Are you a cell biologist, immunologist, or flow cytometrist? If so, you know how challenging it is to find quality contr ...
JAN 09, 2023
Immunology
Disrupted Waste Clearance in the Brain may Cause Neurodegeneration
Disrupted Waste Clearance in the Brain may Cause Neurodegeneration
Treatments that eliminate disruptive protein clumps have not been good at relieving symptoms of dementia, and researcher ...
Loading Comments...